Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
Dupont J, Aghajanian C, Andrea G, Lovegren M, Chuai S, Venkatraman E, Hensley M, Anderson S, Spriggs D, Sabbatini P.
Dupont J, et al. Among authors: aghajanian c.
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:68-73. doi: 10.1111/j.1525-1438.2006.00467.x.
Int J Gynecol Cancer. 2006.
PMID: 16515570